Sign up Australia
Proactive Investors - Run By Investors For Investors

Pressure BioSciences hires NetworkNewsWire for corporate communications

"We look forward to integrating NetworkNewsWire's strategies into our own, " said Scumacher.
Pressure BioSciences hires NetworkNewsWire for corporate communications
The group has hired corporate communications firm NetworkNewsWire (NNW).

Pressure BioSciences Inc (OTCQB: PBIO), the technology and sample market specialist, revealed it had hired corporate communications firm NetworkNewsWire (NNW).

"Our award-winning proprietary technology is being installed in some of the top research laboratories around the world, we have just gone from one to six sales personnel, we will finish the development and release four new instruments to the market over the next 18 months, and our revenue continues to grow year-over-year," said Richard T. Schumacher, president and chief executive in a regulatory statement.

"We look forward to integrating NetworkNewsWire's strategies into our own as we focus on delivering an equitable return to our shareholders by increasing the exposure of our company and its potentially remarkable impact on the life sciences industry."

NNW is a financial news and publishing company, it said.

Its strategies help public and private organizations find their voice and build market visibility.

"Pressure BioSciences has developed a cutting-edge technology that has the potential to play a significant role in a number of commercially important areas," states Sherri Franklin, director of Content Marketing for NNW.

Last week it emerged that Pressure BioSciences was  to collaborate with Phasex Corporation to combine its  exciting ultra shear technology (UST) with the latter's processing methods to develop water-soluble nanoemulsions.

These (nanoemulsions) are mixtures of two or more liquids, which could be used in various products, including  medical, pharmaceuticals, and nutraceuticals, and the companies hope to create a CBD-enriched plant oil.

The UST technology has recently been issued its first two patents in China.

Shares added 3.24% to US$4.14 each

View full PBIO profile View Profile

Pressure BioSciences Inc Timeline

Related Articles

cholesterol on a dial
September 24 2018
"The formation of ProBiotix Health and appointment of Adam Reynolds as chairman continues a successful strategy of building value in each division which is materialised by forming separate legal entities and taking them to a public listing,” said chief executive Stephen O’Hara
Proton Therapy sign
October 10 2018
The broker says the cancer treatment developer could potentially take the entire share of the growth market from ageing cyclotron companies
myLotus kit
August 06 2018
The expansion drive is targeting an estimated 2.3mln women per year in the areas of Hebei, Shanghai, Beijing, Shangdong, Henan and Liaoning

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use